Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1996 Feb 15;15(4):788-98.

EGF or PDGF receptors activate atypical PKClambda through phosphatidylinositol 3-kinase

K Akimoto  1 , R Takahashi, S Moriya, N Nishioka, J Takayanagi, K Kimura, Y Fukui, S i Osada, K Mizuno, S i Hirai, A Kazlauskas, S Ohno
Affiliations

EGF or PDGF receptors activate atypical PKClambda through phosphatidylinositol 3-kinase

K Akimoto et al. EMBO J. .

Abstract

Overexpression of a TPA-insensitive PKC member, an atypical protein kinase C (aPKClambda), results in an enhancement of the transcriptional activation of TPA response element (TRE) in cells stimulated with epidermal growth factor (EGF) or platelet-derived growth factor (PDGF). EGF or PDGF also caused a transient increase in the in vivo phosphorylation level and a change in the intracellular localization of aPKClambda from the nucleus to the cytosol, indicating the activation of aPKClambda in response to this growth factor stimulation. These immediate signal-dependent changes in aKPClambda were observed for a PDGF receptor add-back mutant (Y40/51) that possesses only two of the five major autophosphorylation sites and binds PI3-kinase, and were inhibited by wortmannin, an inhibitor of PI3-kinase. Furthermore, an N-terminal fragment of the catalytic subunit of PI3-kinase, p110alpha, inhibited aPKClambda-dependent activation of TRE in Y40/51 cells stimulated with PDGF. Overexpression of p110alpha resulted in an enhancement of TRE expression in response to PDGF and the regulatory domain of aPKClambda inhibited this TRE activation in Y40/51 cells. These results provide the first in vivo evidence supporting the presence of a novel signalling pathway from receptor tyrosine kinases to aPKClambda through PI3-kinase.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. EMBO J. 1994 Feb 1;13(3):522-33 - PubMed
    1. J Biol Chem. 1994 Feb 4;269(5):3563-7 - PubMed
    1. J Biol Chem. 1994 Feb 4;269(5):3568-73 - PubMed
    1. Nature. 1994 Jan 6;367(6458):40-6 - PubMed
    1. Mol Cell Biol. 1994 Apr;14(4):2577-83 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources